DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-264 Cr | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-264 Cr |
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-264 Cr | Negative | |
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹31,544.8 Cr | 6.3% | 9.6% | 23.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹128,423.0 Cr | -0.4% | 2.9% | 21.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹108,155.0 Cr | 2.1% | -4% | -8.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,924.9 Cr | -0.4% | -0.7% | 17.5% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹71,298.5 Cr | 1.8% | 6.2% | 36.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹42,371.1 Cr | 5.3% | 9% | 7.1% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 6.3% |
9.6% |
23.2% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses